Transcranial Pulse Stimulation (TPS®) is a treatment option that has been approved since 2018 for treating mild to moderate Alzheimer’s disease. The aim of TPS® is to boost the cognitive abilities of people with Alzheimer’s dementia by stimulating various regions of the brain and to maintain these abilities for as long as possible. TPS® treatment is performed on an outpatient basis and is uncomplicated and safe. As a result of the treatments, patients and their relatives have reported improvements in areas including verbal skills, memory, and sense of direction.
The TPS® treatment is carried out by an appropriately trained practitioner with a special device – the NEUROLITH® system. This was developed by the Swiss medical technology manufacturer STORZ MEDICAL, whose products are used not only in neurology but also in other fields including urology, orthopaedics and cardiology. Since the approval of the TPS®, several thousand treatment sessions have already been carried out. In addition to Germany, Austria and Switzerland, TPS® is now also available in England, France, Spain, Denmark, Portugal, Kuwait, Hong Kong, China and Canada.
On our website we have compiled further information for you on the exact function of TPS® and on the sequence of a single TPS® treatment session. You will also find an overview map of treatment centres that already offer the TPS® procedure.
Transcranial Pulse Stimulation with Ultrasound in Alzheimer’s Disease—A New Navigated Focal Brain Therapy
Roland Beisteiner,* Eva Matt, Christina Fan, Heike Baldysiak, Marleen Schönfeld, Tabea Philippi Novak, Ahmad Amini, Tuna Aslan, Raphael Reinecke, Johann Lehrner, Alexandra Weber, Ulrike Reime, Cédric Goldenstedt, Ernst Marlinghaus, Mark Hallett and Henning Lohse-Busch